If You Buy This Industrial Stock Right Now, Could It Make You a Millionaire?
Written by Leo Sun for The Motley Fool -> QuantumScapeโs stock fizzled out as it missed its commercialization targets. But it could finally commercialize its first battery designs next year. QuantumScape (NASDAQ: QS) , a developer of solid-state batteries for electric vehicles
QuantumScapeโs stock fizzled out as it missed its commercialization targets.
But it could finally commercialize its first battery designs next year.
QuantumScape (NASDAQ: QS) , a developer of solid-state batteries for electric vehicles ( EVs ), went public through a merger with a special purpose acquisition company (SPAC) in Nov. 2020. Its stock opened at $24.80 and soared to a record high of $131.67 a month later.
But as of this writing, QuantumScape's stock trades at about $7. It originally planned to commercialize its first batteries in 2024, but it hasn't yet reached that milestone. That sluggish progress drove away its investors, but could it still be a potential millionaire-maker?
Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now, when you join Stock Advisor. See the stocks ยป
QuantumScape's solid-state batteries offer better thermal stability, shorter charging times, and higher charging capacities than lithium-ion batteries. Its QSE-5 battery, co-developed with Volkswagen (OTC:VWAP.Y) over the past decade, has an energy density of 844 Wh/L (watt hours per liter) and can be rapidly charged from 10% to 80% in under 15 minutes.
QuantumScape initially aimed to manufacture the batteries through a joint venture with Volkswagen, but it shifted toward a simpler licensing model in 2024. It now plans to license its technology to Volkswagen's battery subsidiary, PowerCo, as well as other automakers, to generate a recurring stream of higher-margin royalty and licensing revenues.
QuantumScape upgraded its separator process over the past year to improve its cell reliability, equipment productivity, and total yields. It's been producing higher-volume, near-production "B-sample" cells at its Eagle Line pilot production line, and it expects its cash runway to last through 2029, giving it enough time to expand its commercial licensing business.


